Salvia implants first patient with neuromodulation device for severe cluster headache

A woman in Nambour, Australia, is the first patient to receive a minimally invasive implantable neuromodulation device for severe migraine and cluster headache in a first-in-human study conducted by Salvia Bioelectronics BV.

Related Keywords

Australia ,Nambour ,Queensland , ,Salvia Bioelectronics ,Helmholtz Diabetes Center ,Cachexia ,Cancer Induced Cachexia ,Penx Acip ,Neuromodulation ,Migraine ,Salvia Bioelectronics Bv ,Theranica Bio Electronics Ltd ,Cluster Headaches ,Electrocore Inc ,Neurolief Ltd ,